RIM Shoots Self in Foot, Then Puts Foot In Mouth
NEW YORK ( TheStreet) -- There's a saying, "If it wasn't for bad luck, I'd have no luck at all."
This seems to be the prevailing theme for each earnings announcement that requires I first hold my breath before listening to the train wreak that has become
Research in Motion
To describe the nature of the company as an embarrassment would be disrespectful to those of us who suffer real embarrassing moments from time to time for things that are often outside our control.
In the case of RIM, it is remarkable how the company continues to shoot itself in the foot, then firmly plants that foot in its mouth.There is no denying that in the battle for smartphone supremacy against the behemoths of Apple (AAPL) and Google (GOOG) RIM is dead. In fact, the only debate now is whether or not its death was a homicide or a suicide. Who cares? Bottom line is, we now have a dead brand, and a hole needs to be dug. There was a point when I was ready to give the company the benefit of the doubt. But now I just don't see how it can continue to play with investor emotions and get away with it. Sending Mixed Messages What is clear is the company has ceased to make any sort of capital investment in itself to help it compete against its rivals in any meaningful way. Instead, it continues to not only execute poorly but keeps up a recent pattern of saying the wrong things at the wrong times. For example, on Thursday the company said the successful launch of the BlackBerry 10 platform and the delivery of high-quality, full-featured BlackBerry 10 smartphones remain the company's number one priority. Then, in the same breath, it said the BlackBerry 10 smartphones won't be available until the first quarter of next year. Then, the company offered this gem:
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts